_id
691050efccc777a4e85d542c
Ticker
CMOPF
Name
Cosmo Pharmaceuticals N.V
Exchange
PINK
Address
Riverside II, Dublin, Ireland, 2
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
USD
Website
https://www.cosmopharma.com
Description
Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with a faster and less risky excision of gastrointestinal lesions; Lumeblue, a diagnostic drug for the visualisation of colorectal lesions during colonoscopies; Aemcolo/Relafalk, a pharmaceutical drug product in form of tablets that is approved for the treatment of travelers' diarrhoea; and Byfavo, an intravenous benzodiazepine sedative/anesthetic. It is also developing Breezula, a novel androgen receptor inhibitor, which is in Phase III trials and targets androgen receptors in the scalp; Rifamycin 1% enema that is in Phase II clinical trial for the treatment of distal ulcerative colitis and proctitis; Colesevelam, which is in preclinical studies for the treatment of bile acid diarrhea; and Cortexolone 17a-valerate-21-propionate, an oral Androgen receptor and glucocorticoid receptor antagonist that is in Phase I clinical trial for treatment solid tumors, as well as provides Cosmo's AI technology, a GI Genius intelligent endoscopy system. The company has development, distribution, and licensing agreements with Bausch Health, Ferring, China Medical System Holdings Limited, Medtronic, RedHill Biopharma Ltd., Sun Pharmaceutical Industries Ltd., 3SBio, InfectoPharm, and Hyphens Pharma International Limited. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland.
Last Close
132.3
Volume
200
Current Price
135
Change
-3.7
Last Updated
2026-01-02T11:37:16.379Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
2358011648
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
51720000
Cost Of Revenue
25571000
Gross Profit
26149000
Operating Expenses
27560000
Operating Income
-1411000
Interest Expense
-
Pretax Income
-670000
Net Income
-2005999
Eps
-0.12560620206917222
Dividends Per Share
24512000
Shares Outstanding
15938925
Income Tax Expense
1360000
EBITDA
4852000
Operating Margin
-2.72815158546017
Total Other Income Expense Net
741000
Cash
50749000
Short Term Investments
1182000
Receivables
21616000
Inventories
12379000
Total Current Assets
187226000
Property Plant Equipment
29774000
Total Assets
610330000
Payables
11027000
Short Term Debt
756000
Long Term Debt
284000
Total Liabilities
143354000
Equity
460239000
Bs_currency_symbol
EUR
Depreciation
6263000
Change In Working Capital
-5339000
Cash From Operations
900000
Capital Expenditures
2624000
Cash From Investing
41974000
Cash From Financing
-34203000
Net Change In Cash
50749000
Cf_currency_symbol
-
PE
31.7422
PB
4.684572656815264
ROE
-0.4358602812886348
ROA
-0.32867448757229695
FCF
-1724000
Fcf Percent
-0.03333333333333333
Piotroski FScore
2
Health Score
31
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
1.5
Momentum Investing Score
7.5
Net Net Investing Score
1
Quality Investing Score
3
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
51720000
Quarters > 0 > income Statement > cost Of Revenue
25571000
Quarters > 0 > income Statement > gross Profit
26149000
Quarters > 0 > income Statement > operating Expenses
27560000
Quarters > 0 > income Statement > operating Income
-1411000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-670000
Quarters > 0 > income Statement > net Income
-2005999
Quarters > 0 > income Statement > eps
-0.12560620206917222
Quarters > 0 > income Statement > dividends Per Share
24512000
Quarters > 0 > income Statement > shares Outstanding
15970541
Quarters > 0 > income Statement > income Tax Expense
1360000
Quarters > 0 > income Statement > EBITDA
4852000
Quarters > 0 > income Statement > operating Margin
-2.72815158546017
Quarters > 0 > income Statement > total Other Income Expense Net
741000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
50749000
Quarters > 0 > balance Sheet > short Term Investments
1182000
Quarters > 0 > balance Sheet > receivables
21616000
Quarters > 0 > balance Sheet > inventories
12379000
Quarters > 0 > balance Sheet > total Current Assets
187226000
Quarters > 0 > balance Sheet > property Plant Equipment
29774000
Quarters > 0 > balance Sheet > total Assets
610330000
Quarters > 0 > balance Sheet > payables
11027000
Quarters > 0 > balance Sheet > short Term Debt
756000
Quarters > 0 > balance Sheet > long Term Debt
284000
Quarters > 0 > balance Sheet > total Liabilities
143354000
Quarters > 0 > balance Sheet > equity
460239000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-2005999
Quarters > 0 > cash Flow > depreciation
6263000
Quarters > 0 > cash Flow > change In Working Capital
-5339000
Quarters > 0 > cash Flow > cash From Operations
900000
Quarters > 0 > cash Flow > capital Expenditures
2624000
Quarters > 0 > cash Flow > cash From Investing
41974000
Quarters > 0 > cash Flow > cash From Financing
-34203000
Quarters > 0 > cash Flow > net Change In Cash
50749000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.12560620206917222
Quarters > 0 > ratios > PB
4.684572656815264
Quarters > 0 > ratios > ROE
-0.4358602812886348
Quarters > 0 > ratios > ROA
-0.32867448757229695
Quarters > 0 > ratios > FCF
-1724000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.03333333333333333
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
130551000
Quarters > 1 > income Statement > cost Of Revenue
-3285000
Quarters > 1 > income Statement > gross Profit
133836000
Quarters > 1 > income Statement > operating Expenses
71908000
Quarters > 1 > income Statement > operating Income
61928000
Quarters > 1 > income Statement > interest Expense
53000
Quarters > 1 > income Statement > pretax Income
64619000
Quarters > 1 > income Statement > net Income
57245000
Quarters > 1 > income Statement > eps
3.4867669140325117
Quarters > 1 > income Statement > dividends Per Share
32094000
Quarters > 1 > income Statement > shares Outstanding
16417788
Quarters > 1 > income Statement > income Tax Expense
7486000
Quarters > 1 > income Statement > EBITDA
71459000
Quarters > 1 > income Statement > operating Margin
47.435867974967636
Quarters > 1 > income Statement > total Other Income Expense Net
2691000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
44296000
Quarters > 1 > balance Sheet > short Term Investments
98667000
Quarters > 1 > balance Sheet > receivables
18941000
Quarters > 1 > balance Sheet > inventories
13510000
Quarters > 1 > balance Sheet > total Current Assets
202258000
Quarters > 1 > balance Sheet > property Plant Equipment
29088000
Quarters > 1 > balance Sheet > total Assets
646772000
Quarters > 1 > balance Sheet > payables
9100000
Quarters > 1 > balance Sheet > short Term Debt
817000
Quarters > 1 > balance Sheet > long Term Debt
282000
Quarters > 1 > balance Sheet > total Liabilities
141681000
Quarters > 1 > balance Sheet > equity
498330000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
77376000
Quarters > 1 > cash Flow > depreciation
4993000
Quarters > 1 > cash Flow > change In Working Capital
-2625000
Quarters > 1 > cash Flow > cash From Operations
63225000
Quarters > 1 > cash Flow > capital Expenditures
4225000
Quarters > 1 > cash Flow > cash From Investing
-39383000
Quarters > 1 > cash Flow > cash From Financing
-34856000
Quarters > 1 > cash Flow > net Change In Cash
42155500
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
3.4867669140325117
Quarters > 1 > ratios > PB
4.447657937511288
Quarters > 1 > ratios > ROE
11.487367808480323
Quarters > 1 > ratios > ROA
8.850877898239256
Quarters > 1 > ratios > FCF
59000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.4519306631125001
Quarters > 1 > health Score
82
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
136237000
Quarters > 2 > income Statement > cost Of Revenue
23150000
Quarters > 2 > income Statement > gross Profit
113087000
Quarters > 2 > income Statement > operating Expenses
26133000
Quarters > 2 > income Statement > operating Income
86954000
Quarters > 2 > income Statement > interest Expense
60965
Quarters > 2 > income Statement > pretax Income
88748000
Quarters > 2 > income Statement > net Income
75991000
Quarters > 2 > income Statement > eps
4.70525340604719
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
16150246
Quarters > 2 > income Statement > income Tax Expense
12690000
Quarters > 2 > income Statement > EBITDA
94246000
Quarters > 2 > income Statement > operating Margin
63.825539317512856
Quarters > 2 > income Statement > total Other Income Expense Net
1794000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
54556000
Quarters > 2 > balance Sheet > short Term Investments
78858000
Quarters > 2 > balance Sheet > receivables
23649000
Quarters > 2 > balance Sheet > inventories
13902000
Quarters > 2 > balance Sheet > total Current Assets
183594000
Quarters > 2 > balance Sheet > property Plant Equipment
27372000
Quarters > 2 > balance Sheet > total Assets
638252000
Quarters > 2 > balance Sheet > payables
14675000
Quarters > 2 > balance Sheet > short Term Debt
741000
Quarters > 2 > balance Sheet > long Term Debt
422000
Quarters > 2 > balance Sheet > total Liabilities
132866000
Quarters > 2 > balance Sheet > equity
498443000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
75991000
Quarters > 2 > cash Flow > depreciation
7292000
Quarters > 2 > cash Flow > change In Working Capital
2738000
Quarters > 2 > cash Flow > cash From Operations
99186000
Quarters > 2 > cash Flow > capital Expenditures
1428000
Quarters > 2 > cash Flow > cash From Investing
-80120000
Quarters > 2 > cash Flow > cash From Financing
-5368000
Quarters > 2 > cash Flow > net Change In Cash
2140500
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
4.70525340604719
Quarters > 2 > ratios > PB
4.3741876403119315
Quarters > 2 > ratios > ROE
15.245675032049801
Quarters > 2 > ratios > ROA
11.906112319272012
Quarters > 2 > ratios > FCF
97758000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.7175583725419673
Quarters > 2 > health Score
86
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
68118500
Quarters > 3 > income Statement > cost Of Revenue
11575000
Quarters > 3 > income Statement > gross Profit
56543500
Quarters > 3 > income Statement > operating Expenses
12640999
Quarters > 3 > income Statement > operating Income
43477000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
44374000
Quarters > 3 > income Statement > net Income
37995500
Quarters > 3 > income Statement > eps
2.352626703023595
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
16150246
Quarters > 3 > income Statement > income Tax Expense
6345000
Quarters > 3 > income Statement > EBITDA
47123000
Quarters > 3 > income Statement > operating Margin
63.825539317512856
Quarters > 3 > income Statement > total Other Income Expense Net
897000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
54556000
Quarters > 3 > balance Sheet > short Term Investments
19418000
Quarters > 3 > balance Sheet > receivables
23649000
Quarters > 3 > balance Sheet > inventories
13902000
Quarters > 3 > balance Sheet > total Current Assets
183594000
Quarters > 3 > balance Sheet > property Plant Equipment
27372000
Quarters > 3 > balance Sheet > total Assets
638252000
Quarters > 3 > balance Sheet > payables
14675000
Quarters > 3 > balance Sheet > short Term Debt
741000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
132866000
Quarters > 3 > balance Sheet > equity
498443000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
37995500
Quarters > 3 > cash Flow > depreciation
3646000
Quarters > 3 > cash Flow > change In Working Capital
1369000
Quarters > 3 > cash Flow > cash From Operations
49593000
Quarters > 3 > cash Flow > capital Expenditures
714000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-2684000
Quarters > 3 > cash Flow > net Change In Cash
2140500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
2.352626703023595
Quarters > 3 > ratios > PB
4.3741876403119315
Quarters > 3 > ratios > ROE
7.622837516024901
Quarters > 3 > ratios > ROA
5.953056159636006
Quarters > 3 > ratios > FCF
48879000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.7175583725419673
Quarters > 3 > health Score
76
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
266788000
Annuals > 0 > income Statement > cost Of Revenue
19865000
Annuals > 0 > income Statement > gross Profit
246923000
Annuals > 0 > income Statement > operating Expenses
98041000
Annuals > 0 > income Statement > operating Income
148882000
Annuals > 0 > income Statement > interest Expense
125867
Annuals > 0 > income Statement > pretax Income
153367000
Annuals > 0 > income Statement > net Income
133236000
Annuals > 0 > income Statement > eps
8.115344162075914
Annuals > 0 > income Statement > dividends Per Share
32094000
Annuals > 0 > income Statement > shares Outstanding
16417788
Annuals > 0 > income Statement > income Tax Expense
20176000
Annuals > 0 > income Statement > EBITDA
165705000
Annuals > 0 > income Statement > operating Margin
55.805358561854355
Annuals > 0 > income Statement > total Other Income Expense Net
4485000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
44296000
Annuals > 0 > balance Sheet > short Term Investments
98667000
Annuals > 0 > balance Sheet > receivables
18941000
Annuals > 0 > balance Sheet > inventories
13510000
Annuals > 0 > balance Sheet > total Current Assets
202258000
Annuals > 0 > balance Sheet > property Plant Equipment
29088000
Annuals > 0 > balance Sheet > total Assets
646772000
Annuals > 0 > balance Sheet > payables
9100000
Annuals > 0 > balance Sheet > short Term Debt
817000
Annuals > 0 > balance Sheet > long Term Debt
282000
Annuals > 0 > balance Sheet > total Liabilities
141681000
Annuals > 0 > balance Sheet > equity
498330000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
153367000
Annuals > 0 > cash Flow > depreciation
12285000
Annuals > 0 > cash Flow > change In Working Capital
113000
Annuals > 0 > cash Flow > cash From Operations
162411000
Annuals > 0 > cash Flow > capital Expenditures
5653000
Annuals > 0 > cash Flow > cash From Investing
-128881000
Annuals > 0 > cash Flow > cash From Financing
-40224000
Annuals > 0 > cash Flow > net Change In Cash
-5979000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
8.115344162075914
Annuals > 0 > ratios > PB
4.358704778761062
Annuals > 0 > ratios > ROE
26.73649990969839
Annuals > 0 > ratios > ROA
20.600149666343007
Annuals > 0 > ratios > FCF
156758000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.5875751533052461
Annuals > 0 > health Score
89
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
92780000
Annuals > 1 > income Statement > cost Of Revenue
39340000
Annuals > 1 > income Statement > gross Profit
53440000
Annuals > 1 > income Statement > operating Expenses
47294000
Annuals > 1 > income Statement > operating Income
6146000
Annuals > 1 > income Statement > interest Expense
8526000
Annuals > 1 > income Statement > pretax Income
1532000
Annuals > 1 > income Statement > net Income
-4932000
Annuals > 1 > income Statement > eps
-0.30623790214370256
Annuals > 1 > income Statement > dividends Per Share
16890000
Annuals > 1 > income Statement > shares Outstanding
16105126
Annuals > 1 > income Statement > income Tax Expense
6264000
Annuals > 1 > income Statement > EBITDA
19699000
Annuals > 1 > income Statement > operating Margin
6.624272472515629
Annuals > 1 > income Statement > total Other Income Expense Net
-4614000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
50275000
Annuals > 1 > balance Sheet > short Term Investments
-2044339
Annuals > 1 > balance Sheet > receivables
28454000
Annuals > 1 > balance Sheet > inventories
14198000
Annuals > 1 > balance Sheet > total Current Assets
102226000
Annuals > 1 > balance Sheet > property Plant Equipment
28588000
Annuals > 1 > balance Sheet > total Assets
553980000
Annuals > 1 > balance Sheet > payables
8783000
Annuals > 1 > balance Sheet > short Term Debt
897000
Annuals > 1 > balance Sheet > long Term Debt
422000
Annuals > 1 > balance Sheet > total Liabilities
124944000
Annuals > 1 > balance Sheet > equity
422160000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
1532000
Annuals > 1 > cash Flow > depreciation
14261000
Annuals > 1 > cash Flow > change In Working Capital
946000
Annuals > 1 > cash Flow > cash From Operations
22708000
Annuals > 1 > cash Flow > capital Expenditures
4396000
Annuals > 1 > cash Flow > cash From Investing
42303000
Annuals > 1 > cash Flow > cash From Financing
-211266000
Annuals > 1 > cash Flow > net Change In Cash
-135550000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.30623790214370256
Annuals > 1 > ratios > PB
5.047157878055714
Annuals > 1 > ratios > ROE
-1.168277430358158
Annuals > 1 > ratios > ROA
-0.8902848478284415
Annuals > 1 > ratios > FCF
18312000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.19737012287130848
Annuals > 1 > health Score
48
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
102089000
Annuals > 2 > income Statement > cost Of Revenue
18762000
Annuals > 2 > income Statement > gross Profit
83327000
Annuals > 2 > income Statement > operating Expenses
55270000
Annuals > 2 > income Statement > operating Income
28057000
Annuals > 2 > income Statement > interest Expense
9159000
Annuals > 2 > income Statement > pretax Income
24473000
Annuals > 2 > income Statement > net Income
17225000
Annuals > 2 > income Statement > eps
1.0486810210652469
Annuals > 2 > income Statement > dividends Per Share
15607000
Annuals > 2 > income Statement > shares Outstanding
16425395
Annuals > 2 > income Statement > income Tax Expense
6968000
Annuals > 2 > income Statement > EBITDA
46744000
Annuals > 2 > income Statement > operating Margin
27.482882582844383
Annuals > 2 > income Statement > total Other Income Expense Net
-3584000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
185825000
Annuals > 2 > balance Sheet > short Term Investments
55128000
Annuals > 2 > balance Sheet > receivables
38612000
Annuals > 2 > balance Sheet > inventories
11498000
Annuals > 2 > balance Sheet > total Current Assets
306097000
Annuals > 2 > balance Sheet > property Plant Equipment
30277000
Annuals > 2 > balance Sheet > total Assets
759592000
Annuals > 2 > balance Sheet > payables
7588000
Annuals > 2 > balance Sheet > short Term Debt
171827000
Annuals > 2 > balance Sheet > long Term Debt
559000
Annuals > 2 > balance Sheet > total Liabilities
295804000
Annuals > 2 > balance Sheet > equity
456927000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
24473000
Annuals > 2 > cash Flow > depreciation
13856000
Annuals > 2 > cash Flow > change In Working Capital
-13314000
Annuals > 2 > cash Flow > cash From Operations
33226000
Annuals > 2 > cash Flow > capital Expenditures
7310000
Annuals > 2 > cash Flow > cash From Investing
1689000
Annuals > 2 > cash Flow > cash From Financing
-46133000
Annuals > 2 > cash Flow > net Change In Cash
-12735000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
1.0486810210652469
Annuals > 2 > ratios > PB
4.755857628242586
Annuals > 2 > ratios > ROE
3.7697487782512304
Annuals > 2 > ratios > ROA
2.2676647463375077
Annuals > 2 > ratios > FCF
25916000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.25385692875824034
Annuals > 2 > health Score
66
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
65074000
Annuals > 3 > income Statement > cost Of Revenue
15140000
Annuals > 3 > income Statement > gross Profit
49934000
Annuals > 3 > income Statement > operating Expenses
20996000
Annuals > 3 > income Statement > operating Income
11101000
Annuals > 3 > income Statement > interest Expense
8990000
Annuals > 3 > income Statement > pretax Income
24003000
Annuals > 3 > income Statement > net Income
21672000
Annuals > 3 > income Statement > eps
1.2820588663315204
Annuals > 3 > income Statement > dividends Per Share
257998
Annuals > 3 > income Statement > shares Outstanding
16904060
Annuals > 3 > income Statement > income Tax Expense
2330000
Annuals > 3 > income Statement > EBITDA
17811000
Annuals > 3 > income Statement > operating Margin
17.05904047699542
Annuals > 3 > income Statement > total Other Income Expense Net
12902000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
198560000
Annuals > 3 > balance Sheet > short Term Investments
23647000
Annuals > 3 > balance Sheet > receivables
24451000
Annuals > 3 > balance Sheet > inventories
13119000
Annuals > 3 > balance Sheet > total Current Assets
275849000
Annuals > 3 > balance Sheet > property Plant Equipment
30478000
Annuals > 3 > balance Sheet > total Assets
805562000
Annuals > 3 > balance Sheet > payables
4102000
Annuals > 3 > balance Sheet > short Term Debt
889000
Annuals > 3 > balance Sheet > long Term Debt
167145000
Annuals > 3 > balance Sheet > total Liabilities
292884000
Annuals > 3 > balance Sheet > equity
505276000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
24003000
Annuals > 3 > cash Flow > depreciation
7369000
Annuals > 3 > cash Flow > change In Working Capital
-5072000
Annuals > 3 > cash Flow > cash From Operations
12611000
Annuals > 3 > cash Flow > capital Expenditures
8504000
Annuals > 3 > cash Flow > cash From Investing
24857000
Annuals > 3 > cash Flow > cash From Financing
-27247000
Annuals > 3 > cash Flow > net Change In Cash
12623000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
1.2820588663315204
Annuals > 3 > ratios > PB
4.426109963663424
Annuals > 3 > ratios > ROE
4.289140984333315
Annuals > 3 > ratios > ROA
2.6902957190135584
Annuals > 3 > ratios > FCF
4107000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.06311276393029475
Annuals > 3 > health Score
52
Valuation > metrics > PE
31.7422
Valuation > metrics > PB
4.684572656815264
Valuation > final Score
25.063633431847364
Valuation > verdict
41.6% Overvalued
Profitability > metrics > ROE
-0.4358602812886348
Profitability > metrics > ROA
-1.0714318524136603
Profitability > metrics > Net Margin
-0.0387857501933488
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3114772976649089
Risk > metrics > Interest Coverage
-0.25552336110105034
Risk > final Score
59
Risk > verdict
High
Liquidity > metrics > Current Ratio
15.88950182466265
Liquidity > metrics > Quick Ratio
14.838920478655691
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
55.52342062488712
Prev Valuations > 1
56.25812359688069
Prev Valuations > 2
56.25812359688069
Prev Profitabilities > 0
83
Prev Profitabilities > 1
90
Prev Profitabilities > 2
75
Prev Risks > 0
100
Prev Risks > 1
100
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:37:20.447Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-09
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
EUR
Earnings History > 1 > eps Actual
-0.2365
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.2365
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
-0.2338
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.2338
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.2065
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.2065
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.1983
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.1983
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.1169
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.1169
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.1147
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.1147
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.1433
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.1433
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.1393
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.1393
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.8
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.8
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.7891
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.7891
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.3908
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.3908
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.396
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.396
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.3025
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.3025
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.3191
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.3191
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.6053
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.6053
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.5963
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.5963
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.6768
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.6768
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.6321
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.6321
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-12-31
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
0.5126
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0.5126
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-09-30
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
0.5471
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.5471
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-03-31
Earnings History > 21 > report Date
2016-06-30
Earnings History > 21 > date
2016-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
0.216
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0.216
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-12-31
Earnings History > 22 > report Date
2016-03-31
Earnings History > 22 > date
2015-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0.2215
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0.2215
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-09-30
Earnings History > 23 > report Date
2015-12-31
Earnings History > 23 > date
2015-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
0.3025
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.3025
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-06-30
Earnings History > 24 > report Date
2015-09-30
Earnings History > 24 > date
2015-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
0.3108
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0.3108
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-03-31
Earnings History > 25 > report Date
2015-06-30
Earnings History > 25 > date
2015-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
9.1841
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
9.1841
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-12-31
Earnings History > 26 > report Date
2015-03-31
Earnings History > 26 > date
2014-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
8.8575
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
8.8575
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-09-30
Earnings History > 27 > report Date
2014-12-31
Earnings History > 27 > date
2014-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
-0.1484
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.1484
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-06-30
Earnings History > 28 > report Date
2014-09-30
Earnings History > 28 > date
2014-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
-0.1547
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.1547
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2014-03-31
Earnings History > 29 > report Date
2014-06-30
Earnings History > 29 > date
2014-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
3.5957
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
3.5957
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2013-12-31
Earnings History > 30 > report Date
2014-03-31
Earnings History > 30 > date
2013-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
3.619
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
3.619
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2013-09-30
Earnings History > 31 > report Date
2013-12-31
Earnings History > 31 > date
2013-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
EUR
Earnings History > 31 > eps Actual
0.255
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
0.255
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2013-06-30
Earnings History > 32 > report Date
2013-09-30
Earnings History > 32 > date
2013-06-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
EUR
Earnings History > 32 > eps Actual
0.2506
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
0.2506
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2013-03-31
Earnings History > 33 > report Date
2013-06-30
Earnings History > 33 > date
2013-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
EUR
Earnings History > 33 > eps Actual
2.7871
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
2.7871
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2012-12-31
Earnings History > 34 > report Date
2013-03-31
Earnings History > 34 > date
2012-12-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
EUR
Earnings History > 34 > eps Actual
2.7471
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
2.7471
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2012-09-30
Earnings History > 35 > report Date
2012-12-31
Earnings History > 35 > date
2012-09-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
EUR
Earnings History > 35 > eps Actual
0.0293
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
0.0293
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2012-06-30
Earnings History > 36 > report Date
2012-09-30
Earnings History > 36 > date
2012-06-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
EUR
Earnings History > 36 > eps Actual
0.0286
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
0.0286
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2012-03-31
Earnings History > 37 > report Date
2012-06-30
Earnings History > 37 > date
2012-03-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
EUR
Earnings History > 37 > eps Actual
0.8734
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
0.8734
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2011-12-31
Earnings History > 38 > report Date
2012-03-31
Earnings History > 38 > date
2011-12-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
EUR
Earnings History > 38 > eps Actual
0.9185
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
0.9185
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2011-09-30
Earnings History > 39 > report Date
2011-12-31
Earnings History > 39 > date
2011-09-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
EUR
Earnings History > 39 > eps Actual
0.1836
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
0.1836
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2011-06-30
Earnings History > 40 > report Date
2011-09-30
Earnings History > 40 > date
2011-06-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
EUR
Earnings History > 40 > eps Actual
0.1901
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
0.1901
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2011-03-31
Earnings History > 41 > report Date
2011-06-30
Earnings History > 41 > date
2011-03-31
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
EUR
Earnings History > 41 > eps Actual
0.1771
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
0.1771
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2010-12-31
Earnings History > 42 > report Date
2011-03-31
Earnings History > 42 > date
2010-12-31
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
EUR
Earnings History > 42 > eps Actual
0.173
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
0.173
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2010-09-30
Earnings History > 43 > report Date
2010-12-31
Earnings History > 43 > date
2010-09-30
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
EUR
Earnings History > 43 > eps Actual
0.0865
Earnings History > 43 > eps Estimate
0
Earnings History > 43 > eps Difference
0.0865
Earnings History > 43 > surprise Percent
-
Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with a faster and less risky excision of gastrointestinal lesions; Lumeblue, a diagnostic drug for the visualisation of colorectal lesions during colonoscopies; Aemcolo/Relafalk, a pharmaceutical drug product in form of tablets that is approved for the treatment of travelers' diarrhoea; and Byfavo, an intravenous benzodiazepine sedative/anesthetic. It is also developing Breezula, a novel androgen receptor inhibitor, which is in Phase III trials and targets androgen receptors in the scalp; Rifamycin 1% enema that is in Phase II clinical trial for the treatment of distal ulcerative colitis and proctitis; Colesevelam, which is in preclinical studies for the treatment of bile acid diarrhea; and Cortexolone 17a-valerate-21-propionate, an oral Androgen receptor and glucocorticoid receptor antagonist that is in Phase I clinical trial for treatment solid tumors, as well as provides Cosmo's AI technology, a GI Genius intelligent endoscopy system. The company has development, distribution, and licensing agreements with Bausch Health, Ferring, China Medical System Holdings Limited, Medtronic, RedHill Biopharma Ltd., Sun Pharmaceutical Industries Ltd., 3SBio, InfectoPharm, and Hyphens Pharma International Limited. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAI colonoscopy tools and new skin, hair-loss treatments mark Cosmo's shift Stock Titan
Read more →Cosmo shares skyrocket after male hair loss treatment hits key trial goals (CMOPF:OTCMKTS) Seeking Alpha
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Cosmo Pharmaceuticals N.V
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.2365
EPS Estimate
0
EPS Difference
-0.2365
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.